Minister Harris announces a new programme to advance clinical research capability among doctors

14 Sep 2016
Pictured at the announcement of the Wellcome – HRB Irish Clinical Academic Training Programme, were Professor Conall Dennedy, NUI, Galway; Professor Ray Stallings, RCSI;Professor Paddy Mallon, University College Dublin; Dr Graham Love, Chief Executive, Health Research Board; Simon Harris, TD, Minister for Health;Professor Michael Gill, the Principal Investigator on the Wellcome-HRB Irish Clinical Academic Training Programme: Prof Mary Horgan, University College Cork, Professor Peter Maxwell, Queen’s University Belfast; Dr Mark Watson, Molecular Medicine Ireland.

A team of Irish clinical academics have secured one of seven major awards that have been made across the UK and Ireland by Wellcome*. 

The scheme, which will be known as Wellcome – HRB Irish Clinical Academic Training Programme, will support the intake of eight postgraduate trainee doctors a year for a five-year period, providing fully integrated clinical and research training up to consultant level.

The award represents an overall investment of almost €13 million with €7.5 million coming from Wellcome and the Health Research Board (HRB) matched with a further combined contribution of €5.5 million from the Health Service Executive and the Health and Social Care Research and Development Office, Northern Ireland, and the partner Universities.

The programme will be open to applications in autumn 2016 for an intake beginning in July 2017. An overview of the course breakdown is presented in the notes to editors below.

‘A research-active health system is proven to have better outcomes for patients’, said Minister for Health Simon Harris, announcing the programme today. ‘Patients will be the long-term winners as this collaborative investment will fundamentally improve both the number and calibre of Clinician Scientists working in our universities and health services.  I'm really pleased to announce this significant investment in the future of the health service, and I know the positive impact for patient care is going to be very real.  I very much look forward to seeing this important programme in action over the next few years.

I welcome the strong collaboration that is core to this research award, and I am particularly pleased that Northern Ireland is part of it, making this an all island and multi-institutional Programme’.

The north’s Health Minister, Michelle O Neill said;

‘This is the largest ever investment in academic medicine through an all island collaborative partnership and it will make a real difference to the health of people across the island of Ireland and further afield.

I want to congratulate all those involved in securing this programme and in particular pay tribute to the role played by Professor Peter Maxwell, from Queen’s University in Belfast.   This initiative demonstrates what can be achieved through collaborative working across the whole island of Ireland.’

The partner universities involved in the programme include Trinity College Dublin, University College Dublin, NUI Galway, University College Cork, Royal College of Surgeons in Ireland and Queen’s University Belfast. Each academic partner is affiliated to hospitals and hospital groups in their region. A crucial coordinating role was played by Molecular Medicine Ireland, the collaborative entity owned by the university partners.

Professor Michael Gill the Principal Investigator on the Wellcome-HRB Irish Clinical Academic Training Programme said,

‘Our goal in securing this award was to enable a fundamental change in the training of future academic clinicians on an all-Ireland basis. At its core is a fully integrated clinical and research programme that will provide seamless, supported and mentored training of the highest standard, targeting future clinical academic leaders in the universities and health care system.

The programme will identify, recruit, and mentor doctors during their postgraduate training who have the potential to become future academic leaders. They will be supported through a structured career pathway, aligned with our national research strengths and postgraduate specialities. In doing so, this programme will position Ireland well to meet future challenges in clinical innovation and excellence in healthcare.

Our application has the full support of all major stakeholders; the Postgraduate Forum representing specialist training bodies, the Health Services North and South, the Universities and the Health Research Board.  Trainee Clinician Scientists will be based at six major Irish universities in Belfast, Cork, Dublin and Galway, and will be able to take advantage of existing clinical research infrastructures and supports in their associated hospitals, many of which have been funded by the HRB.’

According to Dr Graham Love Chief Executive at the Health Research Board,

‘We are committed to fostering a research-active culture among health professionals so they can continually evolve and improve care.  It is great to see that the ongoing collaboration between the HRB and Wellcome Trust continues to extend new opportunities to researchers in Ireland.’

Dr Anne-Marie Coriat, Head of Research Careers at Wellcome said;

‘This is one of seven new clinical PhD programmes across the UK and Ireland that Wellcome has funded.  Training small groups of PhD students in programmes provides an opportunity to develop cohort focussed training opportunities and further embed clinical academic training within universities and university hospitals.’

Research and Innovation

Taighde agus Nuálaíocht

Office of Vice President for Research & Innovation 4th Floor Block E, Food Science Building UCC